Abstract:Abstract Background Advances in unbiased metagenomic next generation sequencing (mNGS) technologies have enabled the study of microbial and host genetic material (DNA and RNA) in one test. In this study, we aimed to develop machine learning-based differential diagnostic models (MLBDDMs) using the metagenomic and human transcriptomic data generated by an affordable bronchoalveolar lavage fluid (BLAF) mNGS assay and investigated their clinical utility for early differential diagnosis of lung cancer and pulmonary infection in patients with pulmonary diseases. Methods We recruited 775 patients with respiratory disease, including 160 pathologically diagnosed lung cancer and clinically diagnosed 615 infectious causes (131 tuberculosis, 172 fungal pneumonia and 312 bacterial pneumonia). An affordable mNGS assay on BALF samples collected from these patients on admission were performed. Using the generated mNGS data, we compared the differences in microbial diversity and host gene expression between lung cancer patients and pulmonary infection patients. The BLAF mNGS datasets of lung cancer group and each infection group were then randomly divided into a training dataset and a validation dataset at a ratio of approximately 3:1 for developing optimal MLBDDMs that can be used to distinguish lung cancer from various pulmonary infections. Results By comparing the BALF mNGS data of lung cancer (n = 160) and pulmonary infection (n = 615), we found that the infection group had higher microbial diversity than lung cancer group (P-value < 0.05). Respiratory colonizing microorganisms (e.g., Corynebacterium propinquum and Bacteroides uniformis) and pathogen (Mycobacterium tuberculosis and Cryptococcus neoformans) were found as differential microbes (adjusted p-value < 0.05, LDA score > 2). From BALF gene expression data, we detected 175 genes enriched in NOD-like receptor signaling pathway and chemokine signaling pathway differentially expressed between lung cancer and pulmonary infection groups (False Discovery Rate, FDR < 0.05). Cell composition analysis revealed that macrophage M1 was higher in lung infection group (P-value < 0.001), whereas mast cell activated and DCs activated were higher in lung cancer group (P-value < 0.001, P-value = 0.016). We integrated the metagenomic (microbial composition and human copy number variation) and transcriptomic data (host differentially expressed genes and cell composition) generated by the BALF mNGS assay with eleven machine learning classifiers to establish diagnosis models for distinguishing lung cancer from pulmonary infection (we named LC/PI model). The results showed that a Random Forest diagnostic model (the RF-LC/PI model) had optimal performance, with a sensitivity and specificity of 86.7% and 87.8%, respectively, in distinguishing lung cancer from pulmonary infection (area under the receiver operating characteristic curve [AUC] = 0.838 in the training dataset; AUC = 0.79 in a held-out validation dataset). Similar to the establishment of the LC/PI model, we further developed three diagnostic models for distinguishing lung cancer and tuberculosis (LC/TB model), lung cancer and fungal pneumonia (LC/FP model), and lung cancer and bacterial pneumonia (LC/BP model), respectively. The AUC of these three models were 0.91, 0.88, 0.91, respectively, showing a high differential diagnosis accuracy. Conclusions We have established MLBDDMs using BALF metagenomic and metatranscriptomic data and achieved superior accuracy for differentiating lung cancer and pulmonary infections, which could promote early diagnosis of pulmonary diseases and benefit more patients with one test.

Study on the Infectious Regularity of Patients with Advanced Lung Cancer

Clinical Characteristics Analysis and Construction of a Predictive Diagnostic Model of Community-Acquired Pneumonia in Adults Requiring Hospitalization in Fujian Provincial Hospital

Use of an Artificial Neural Network to Construct a Model of Predicting Deep Fungal Infection in Lung Cancer Patients

A-242 Integrating Respiratory Metagenomics and Metatranscriptomics for Diagnosis of Lung Cancer and Infection in Patients with Pulmonary Diseases

Detection of relationship between pathogens of acute exacerbation of chronic obstructive pulmonary disease and comprehensive evaluation classification

ANALYSIS OF PATHOGENIC BACTERIA AND DRUG RESISTANCE OF RESPIRATORY INFECTION ON THE INTERMEDIATE-ADVANCED STAGE LUNG CANCER PATIENTS

Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer

Establishment of a Risk Prediction Model for Pulmonary Infection in Patients with Advanced Cancer

Application of data mining in computer-aided diagnosis of lung cancer

Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data

Research on etiological feature of hospital infection with lung cancer chemotherapy patients

Machine-learning based prediction of prognostic risk factors in patients with invasive candidiasis infection and bacterial bloodstream infection: a singled centered retrospective study

Characteristics of pathogenic microbes in lung microenvironment of lung cancer patients without respiratory infection

Using time-series chest radiographs and laboratory data by machine learning for identifying pulmonary infection and colonization of Acinetobacter baumannii

Impact on hospitalization and infection patterns of advanced lung cancer with lower respiratory tract infections: Targeted therapy vs. chemoradiotherapy

Study on the application of metagenomic next generation sequencing in interstitial lung disease patients with pulmnonary infection

Identification of non-small cell lung cancer with chronic obstructive pulmonary disease using clinical symptoms and routine examination: a retrospective study

A machine learning model for early candidemia prediction in the intensive care unit: Clinical application

Study on Peripheral Blood T Lymphocyte Subsets of Patients with Lung Cancer and Lung Infection

Bronchoalveolar lavage fluid metagenomic next-generation sequencing assay for identifying pathogens in lung cancer patients

Prediction of Lung Infection during Palliative Chemotherapy of Lung Cancer Based on Artificial Neural Network